Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study
Anastasios Kartas, Ioannis Doundoulakis, Despoina Ntiloudi, Athanasios Koutsakis, Diamantis Kosmidis, Georgios Rampidis, Sotiria Apostolopoulou, Alexandra Frogoudaki, Afrodite Tzifa, Dimosthenis Avramidis, Olga Ntzoyvara, Sotiria Liori, Tereza Mousiama, Sophia Anastasia Mouratoglou, Haralambos Karvounis, George Giannakoulas
BMJ Open Sep 2020, 10 (9) e038012; DOI: 10.1136/bmjopen-2020-038012